INS and metabolic dysfunction-associated steatotic liver disease: Upon administration of the extracellular CTSD inhibitor, we observed that HFD-fed rats showed a significant reduction in plasma insulin levels and improvement of steatosis, two important characteristics of diet-induced NAFLD.